More importantly, qRT–PCR and western blot analysis on tissues from CRC patients showed much higher EGFR and TNS4 expression in SMARCA4-R1157W mutant CRCs compared to SMARCA4-WT CRCs (Fig. 3j, k), consistent with the results of cellular experiments. This evidence concerns the gene EGFR and colorectal carcinoma.